Sézary Syndrome — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Sézary syndrome
Sézary syndrome is the leukaemic variant of cutaneous T-cell lymphoma, defined by the triad of erythroderma, lymphadenopathy, and circulating Sézary cells (atypical cerebriform T lymphocytes) >1000/μL in peripheral blood. It is classified as stage IVA1 or higher mycosis fungoides/Sézary syndrome. Flow cytometry typically shows CD4+CD7- or CD4+CD26- phenotype. Management includes extracorporeal photopheresis, low-dose Methotrexate, and systemic therapies. Prognosis is poorer than patch/plaque stage mycosis fungoides.
Reference: BAD 2019 Guidelines for management of CTCL; EORTC-ISCL